Education

• 1993 MD: 110/110 cum laude.
• 1999 Fellowship in Gastroenterology and Digestive Endoscopy
• 2004 PhD in Hepato-Gastroenterology

Biography

I’m a specialist in gastroenterology and digestive endoscopy with a PhD in hepato-gastroenterological sciences; I have a special interest focused on digestive endoscopy (diagnostic and operative) and immunology disorders of GI tract (i.e., Inflammatory Bowel Disease).

Presently, I’m working as Consultant Physician & Gastroenterologist, Barts Health University Trust, London, UK and as GI Consultant, Department of Gastroenterology and Digestive Endoscopy; previously, I was the head of outpatient clinic for inflammatory bowel disease and gastro-immunologic diseases at the Jewish Hospital of Rome, Italy.

I was appointed Young European Assessors at AIFA (Italian Drug Agency) for immunology and gastroenterology and worked as external consultant for some pharmaceutical companies within inflammatory/autoimmunity field.

Research Interest

Inflammatory Bowel Disease and Gastro-Immunologic Diseases
Digestive Endoscopy (Diagnostic and Operative procedures)
Gastroesophageal Reflux Disease
Peptic Ulcer and H. pylori infection

Professional Activities:

Clinical experience abroad

• 1993: Department of Medicine: Division of Gastroenterology, Mount Sinai School of Medicine, New York, NY, USA
• 1994: St. Bartholomew’s Hospital and Homerton Hospital, London, UK
• 2010: Visiting physician at IBD center, Department of Gastroenterology and Digestive Endoscopy, Tel Aviv Sourasky Medical Center Israel

Employment

Publications

1. Fistulizing Crohn’s disease complicated by hidden retroperitoneal  abscess: a case report and review of the literature. Caviglia R, Di Castro A., Cannaviello C. Gastro Open J . 2014; 1(1): 3-6
2. Upper Gastrointestinal Involvement of Crohn's Disease: A Prospective Study on the Role of Upper Endoscopy in the Diagnostic Work-Up. Annunziata ML, Caviglia R, Papparella LG, Cicala M.  Dig Dis Sci. 2012.
3. Maintenance treatment with infliximab for the management of Crohn’s disease in adults. Caviglia R, Boškoski I, Cicala M. Biologics: Targets & Therapy. 2009:3 39-4. Review. 
4. Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid. Guarino MP, Carotti S, Morini S, Perrone G, Behar J, Altomare A, Alloni R, Caviglia R, Emerenziani S, Rabitti C, Cicala M. Gut. 2008 Dec;57(12):1740-1.
5. Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparison between light and electron microscopy analysis. Ribolsi M, Perrone G, Caviglia R, Gentile M, Emerenziani S Guarino MP, Petitti T, Cicala M. Dig Liver Dis. 2009 Jan;41(1):9-14.
6. Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues. Caviglia R, Boškoski  I, Cicala M. Expert Opin Drug Saf  2008 Sep;7(5):617-32. Review.
7. Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up. Caviglia R, Ribolsi M, Rizzi M, Emerenziani S, Annunziata ML, Cicala M. World J Gastroenterol. 2007 Oct 21;13(39):5238-44.
8. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Emerenziani S, Sifrim D, Habib FI, Ribolsi M, Guarino MP, Rizzi M, Caviglia R, Petitti T, Cicala M. Gut. 2008 Apr;57(4):443-7.
9. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Del Vescovo R, Sansoni I, Caviglia R, Ribolsi M, Perrone G, Leoncini E, Grasso RF, Cicala M, Zobel BB. Abdom Imaging. 2008 Jul-Aug;33(4):417-24.
10. Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. Emerenziani S, Cicala M, Zhang X, Ribolsi M, Caviglia R, Guarino MP, Sifrim D. Neurogastroenterol Motil. 2007 Jun;19(6):459-64.
11. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MP, Petitti T, Cicala M. Aliment Pharmacol Ther. 2007 Mar 1;25(5):629-36.
12. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients. Emerenziani S, Habib FI, Ribolsi M, Caviglia R, Guarino MP, Petitti T, Cicala  M. Aliment Pharmacol Ther. 2006 Mar 15;23(6):751-7.
13. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus. Merola E, Mattioli E, Minimo C, Zuo W, Rabitti C, Cicala M, Caviglia R, Pollice L, Gabbrielli A, Giordano A, Claudio PP. J Cell Physiol. 2006 May;207(2):512-9.
14. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease. Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M. Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71.
15. Dilated intercellular spaces of esophageal epithelium in non-erosive reflux disease patients with physiological esophageal acid exposure. Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP, Carotti S, Habib FI, Rabitti C, Cicala M. Am J Gastroenterol. 2005 Mar;100(3):543-8.
16. Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intra-oesophageal dynamic characteristics of acid reflux. Cicala M, Gabbrielli A, Emerenziani S, Guarino MP, Ribolsi M, Caviglia R, Costamagna G. Gut. 2005 Feb;54(2):183-6.
17. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro oesophageal reflux disease. Cicala M, Emerenziani S, Caviglia R, Guarino MP, Vavassori P, Ribolsi M, Carotti S, Petitti T, Pallone F. Aliment Pharmacol Ther. 2003 Sep 15;18(6):605-13.
18. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
19. Annovazzi A, Biancone L, Caviglia R, Chianelli M, Capriotti G, Mather SJ, Caprilli R, Pallone F, Scopinaro F, Signore A. Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):374-82.
20. Turcot syndrome: case report and nosological aspects. Fracasso P, Caviglia R, Grassi A, Lapenta R, Stigliano V, Franco D, Casale V. J Exp Clin Cancer Res. 1997 Dec;16(4):433-5.